{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:14:33Z","timestamp":1790813673138,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bbrc.2019.07.026","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T07:59:08Z","timestamp":1568275148000},"page":"415-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A novel SCNN1G mutation in a PHA I infant patient correlates with nephropathy"],"prefix":"10.1016","volume":"519","author":[{"given":"Li-Ping","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Yuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2019.07.026_bib1","first-page":"1","article-title":"Clinical and molecular features of type 1 pseudohypoaldosteronism","volume":"72","author":"Riepe","year":"2009","journal-title":"Horm. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2019.07.026_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1297\/cpe.26.109","article-title":"Clinical features and molecular basis of pseudohypoaldosteronism type 1","volume":"26","author":"Tajima","year":"2017","journal-title":"Clin. Pediatr. Endocrinol."},{"issue":"7","key":"10.1016\/j.bbrc.2019.07.026_bib3","first-page":"395","article-title":"The ENaC channel as the primary determinant of two human diseases: liddle syndrome and pseudohypoaldosteronism","volume":"17","author":"Schild","year":"1996","journal-title":"Nephrologie"},{"issue":"8","key":"10.1016\/j.bbrc.2019.07.026_bib4","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.bpj.2011.02.046","article-title":"Voltage-dependent gating underlies loss of ENaC function in Pseudohypoaldosteronism type 1","volume":"100","author":"Kucher","year":"2011","journal-title":"Biophys. J."},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2019.07.026_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jsbmb.2010.01.002","article-title":"Truncated beta epithelial sodium channel (ENaC) subunits responsible for multi-system pseudohypoaldosteronism support partial activity of ENaC","volume":"119","author":"Edelheit","year":"2010","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"issue":"9\u201310","key":"10.1016\/j.bbrc.2019.07.026_bib6","first-page":"1035","article-title":"A\u00a0novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism Type 1","volume":"25","author":"Dogan","year":"2012","journal-title":"J.\u00a0Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2019.07.026_bib7","first-page":"150104","article-title":"Pseudohypoaldosteronism type 1 due to novel variants of SCNN1B gene","author":"Nobel","year":"2016","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"issue":"5","key":"10.1016\/j.bbrc.2019.07.026_bib8","first-page":"497","article-title":"Pseudohypoaldosteronism type 1 in an Omani male infant simulating salt-losing congenital adrenal hyperplasia","volume":"21","author":"Khan","year":"2000","journal-title":"Saudi Med. J."},{"issue":"1","key":"10.1016\/j.bbrc.2019.07.026_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12098-011-0490-1","article-title":"Pseudohypoaldosteronism masquerading as congenital adrenal hyperplasia","volume":"79","author":"Delhikumar","year":"2012","journal-title":"Indian J. Pediatr."},{"issue":"3","key":"10.1016\/j.bbrc.2019.07.026_bib10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ekir.2018.01.004","article-title":"Secondary pseudohypoaldosteronism masquerading congenital adrenal hyperplasia in a neonate","volume":"3","author":"Sethi","year":"2018","journal-title":"Kidney Int. Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2019.07.026_bib11","first-page":"363","article-title":"Gene symbol: CYP21A2. Disease: adrenal hyperplasia, CYP21","volume":"119","author":"Dain","year":"2006","journal-title":"Hum. Genet."},{"issue":"Suppl 12","key":"10.1016\/j.bbrc.2019.07.026_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12859-016-1190-7","article-title":"Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data","volume":"17","author":"do Valle","year":"2016","journal-title":"BMC Bioinf."},{"issue":"16","key":"10.1016\/j.bbrc.2019.07.026_bib13","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bbrc.2019.07.026_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A\u00a0program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly"},{"issue":"3","key":"10.1016\/j.bbrc.2019.07.026_bib15","doi-asserted-by":"crossref","first-page":"E467","DOI":"10.1152\/ajpendo.00066.2011","article-title":"A\u00a0homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1","volume":"301","author":"Dirlewanger","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bbrc.2019.07.026_bib16","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.3390\/ijms15034007","article-title":"miR-21 promotes human nucleus pulposus cell proliferation through PTEN\/AKT signaling","volume":"15","author":"Liu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbrc.2019.07.026_bib17","article-title":"MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbrc.2019.07.026_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/cns.12785","article-title":"MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN\/PI3K\/AKT signaling pathway","volume":"24","author":"Chai","year":"2018","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.bbrc.2019.07.026_bib19","first-page":"571","article-title":"PTEN promotes apoptosis of H2O2injured rat nasal epithelial cells through PI3K\/Akt and other pathways","volume":"17","author":"Jia","year":"2018","journal-title":"Mol. Med. Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19313622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19313622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:40:57Z","timestamp":1757763657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19313622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0006291X19313622"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.07.026","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel SCNN1G mutation in a PHA I infant patient correlates with nephropathy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}